SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UBS Maintains Neutral on DexCom, Raises Price Target to $185

UBS maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $160 to $185.

Benzinga · -

UBS maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $160 to $185.